CAS RN: 54584-22-4
6-HYDROXY-2-METHYLINDOLE
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250321
50mg / 250mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 54584-22-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
54584-22-4 / 2-methyl-1H-indol-6-ol
Standard CAS: 54584-22-4
Multi CAS: No
Basic Information
copy
CAS
54584-22-4 copy
Multi CAS
No copy
Molecular Formula
C9H9NO copy
Molecular Weight
147.170000 copy
Exact Mass
147.068414 copy
InChI
InChI=1S/C9H9NO/c1-6-4-7-2-3-8(11)5-9(7)10-6/h2-5,10-11H,1H3 copy
InChIKey
JKIGVFLHAJUPCP-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.11 copy
H-bond acceptors
1 copy
H-bond donors
2 copy
Molar refractivity
44.7 copy
TPSA
36.02 copy
LogP / Solubility
WLOGP
2.18 copy
MLOGP
1.91 copy
XLogP3
2.2 copy
Consensus LogP
2.1 copy
Log S (ESOL)
-2.73 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.34 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.43 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.07 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy